Stock KPL6 KWALITY PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Kwality Pharmaceuticals Limited

Equities

KPL6

INE552U01010

Market Closed - Bombay S.E.
Other stock markets
 06:00:49 2024-04-25 am EDT 		5-day change 1st Jan Change
500.2 INR -1.43% Intraday chart for Kwality Pharmaceuticals Limited +10.58% +25.11%
Feb. 06 Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 Kwality Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Kwality Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Kwality Pharmaceuticals Limited Provides Update on Resumption of Operations At Amritsar
CI
Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Kwality Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
Kwality Pharmaceuticals Discloses Completion of EU GMP Inspection at Himachal Pradesh, India Unit
MT
Kwality Pharmaceuticals Limited Receives ANVISA Approval for Cephalosporin Plant (Unit -II)
CI
Kwality Pharmaceuticals Limited Announces Change in Directorate
CI
Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Bulgarian Drug Agency to Conduct Audit on Kwality Pharmaceuticals' Plant in Himachal Pradesh, India
MT
Kwality Pharmaceuticals to Bring Oncology Injection in Brazil
MT
Kwality Pharmaceuticals to Market Oncology Injection in Brazil
MT
Kwality Pharmaceuticals Received ANVISA Approval For Oncology Injection
CI
Kwality Pharmaceuticals Receives ANVISA Approval For Oncology Injection
CI
Kwality Pharmaceuticals Limited Announces the Resignation of Sachin Seth as Non- Executive and Non Independent Director
CI
Kwality Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
ICRA Assigns BBB Rating on Kwality Pharmaceuticals' Bank Loans; Outlook Stable
MT
Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
Kwality Pharmaceuticals Gets In-Principle Approval to Migrate to BSE Main Board
MT
Kwality Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KPL6 Stock
  4. News Kwality Pharmaceuticals Limited